Welcome! Here you can find resources created for patients treated with COVID-19 antibody therapeutics.
This discharge education is meant to support, but not replace, discharge instructions provided from your infusion center. (Updated 5-20-21)
Use these resources to identify sites of care administering COVID-19 antibody therapeutics.
The CDC has developed the COVID-19 Communication Toolkit: For Migrants, Refugees, and Other Limited-English-Proficient Populations in various languages. Resources are available in Spanish, Simplified Chinese, Korean, Tagalog, Hmoob (Hmong), Af Soomaali (Somali), and Vietnamese.
If you had a serious side effect after receiving a COVID-19 infusion therapy (e.g. hospitalization, life-threatening adverse event, or any other event that significantly disrupted the ability to perform normal activities of daily living), it should be reported to the FDA MedWatch program.